The exposome in rheumatoid arthritis.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
11 2022
Historique:
received: 18 06 2022
revised: 08 07 2022
accepted: 25 07 2022
pubmed: 15 8 2022
medline: 24 11 2022
entrez: 14 8 2022
Statut: ppublish

Résumé

The exposome integrates the variety and accumulation of exposures (external and internal) to which an individual is submitted to from conception to death. Exposome may therefore be a useful tool for understanding the diversity of these factors and their role in the pathophysiology of rheumatoid arthritis (RA). Life is perceived as a continuum of cumulative changes, with key periods of disruption (e.g. birth, adolescence, pregnancy, prolonged treatment). The combination of these changes and the external signals that cause them constitute an individual's exposome, which is constantly changing and expanding throughout life. Thus, measuring the exposome requires specific tools and approaches as well as a global perspective. RA, a complex, heterogeneous, pro-inflammatory autoimmune disease with a genetic component and for which a large number of environmental factors have already been incriminated is an appropriate field of application for the exposome. The aim of this review is to define the exposome concept, outline the different analytic tools available for its study and finally apply them to the field of RA.

Identifiants

pubmed: 35964886
pii: S1297-319X(22)00115-4
doi: 10.1016/j.jbspin.2022.105455
pii:
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105455

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Auteurs

Jerome Biton (J)

Inserm U1125, Bobigny, France; Université Sorbonne Paris Nord, UFR SMBH, Li2P, Bobigny, France.

Nathalie Saidenberg-Kermanac'h (N)

Rheumatology department, Avicenne university hospital, Assistance publique-Hôpitaux de Paris, Bobigny, France.

Patrice Decker (P)

Inserm U1125, Bobigny, France; Université Sorbonne Paris Nord, UFR SMBH, Li2P, Bobigny, France.

Marie-Christophe Boissier (MC)

Inserm U1125, Bobigny, France; Université Sorbonne Paris Nord, UFR SMBH, Li2P, Bobigny, France; Rheumatology department, Avicenne university hospital, Assistance publique-Hôpitaux de Paris, Bobigny, France.

Luca Semerano (L)

Inserm U1125, Bobigny, France; Université Sorbonne Paris Nord, UFR SMBH, Li2P, Bobigny, France; Rheumatology department, Avicenne university hospital, Assistance publique-Hôpitaux de Paris, Bobigny, France.

Johanna Sigaux (J)

Inserm U1125, Bobigny, France; Université Sorbonne Paris Nord, UFR SMBH, Li2P, Bobigny, France; Rheumatology department, Avicenne university hospital, Assistance publique-Hôpitaux de Paris, Bobigny, France. Electronic address: johanna.sigaux@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH